Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19.

Nasser, Nourhane; Kurban, Mazen; Abbas, Ossama

Nasser, Nourhane; Kurban, Mazen; Abbas, Ossama.

Nasser N; Department of Dermatology, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh, 1107 2020, Lebanon.
Kurban M; Department of Dermatology, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh, 1107 2020, Lebanon.
Abbas O; Department of Dermatology, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh, 1107 2020, Lebanon. ossamaabbas2003@yahoo.com.

Rheumatol Int ; 41(5): 1019-1020, 2021 05.

Article in English | MEDLINE | ID: covidwho-1118221

Subject(s)

COVID-19; Interferon Type I; Lupus Erythematosus, Systemic; Dendritic Cells; Humans; Lupus Erythematosus, Systemic/drug therapy; SARS-CoV-2

Keywords

Interferon; Plasmacytoid dendritic cell; SARS-Cov-2; SLE

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / COVID-19 / Lupus Erythematosus, Systemic Limits: Humans Language: English Journal: Rheumatol Int Year: 2021 Document Type: Article Affiliation country: S00296-021-04825-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google